Tag: Janssen

Janssen stops the trials of Daratumumab

janssen j&j
Genmab announced that the DMC has recommended that the Phase Ib/II study of daratumumab in combination with atezolizumab versus atezolizumab monotherapy should be terminated.

Janssen Biotech will buy BeneVir Biopharm

Janssen Biotech, one of the Janssen Pharmaceutical Companies of Johnson & Johnson, will acquire BeneVir Biopharm, a privately-held, biopharmaceutical company specializing in the development of oncolytic immunotherapies.

BMS will collaborate with Janssen on a novel cardiovascular therapy

Bristol-Myers Squibb announced a worldwide collaboration with Janssen Pharmaceuticals on a Factor XIa inhibitor program that includes the development and commercialization of Bristol-Myers Squibb’s Factor XIa inhibitor.

Janssen intends to manufacture bedaquiline at the Pharmstandard plant in Ufa

Janssen Pharmaceutica N.V., a part of Janssen Pharmaceutical Companies of Johnson & Johnson, signed a memorandum of intent with Pharmstandard JSC to manufacture and supply Sirturo®, a medicinal product.

Theravance Biopharma and Janssen entered into drug development collaboration

Theravance Biopharma Ireland announced that it has entered into a global co-development and commercialization agreement with Janssen Biotech, Inc., for TD-1473 and related back-up compounds for inflammatory intestinal diseases

Johnson & Johnson Innovation creates a research incubator in Belgium

test tubes
The Belgium-based JLINX incubator – a collaboration launched in March 2016 between Janssen Pharmaceutica NV and Bioqube Ventures – will become part of the global Johnson & Johnson Innovation network

Janssen entered into collaboration with Chinese Genscript Biotech

janssen j&j
Janssen Biotech has entered into a worldwide collaboration and license agreement with Legend Biotech USA Inc. and Legend Biotech Ireland Limited

SKOLKOVO Foundation and Janssen signed a collaboration agreement

Kirill Kaem, Senior Vice-President at SKOLKOVO Foundation, and Luis Diaz-Rubio, Managing Director at Janssen, signed a collaboration agreement

Janssen and Zymeworks become partners in drug development

drug development
Zymeworks Inc announced it has executed a licensing agreement with Janssen Biotech

First anti-CD38 monoclonal antibody is registered in the Russian Federation

janssen j&j
Janssen announced the market launch of Darzalex, a drug that received the certificate of state registration in the Russian Federation

BioMed X and Janssen will cooperate on biomedical research projects

The BioMed X Innovation Center announced today a collaboration agreement with Janssen Research & Development to foster early-stage preclinical biomedical research and development projects

Janssen Sciences starts an expansion of its facility in Ireland

janssen j&j
Janssen Sciences, a a subsidiary of Johnson & Johnson, announced an expansion of its Irish facility located in Cork

Janssen entered into license agreement with Provention Bio

janssen j&j
Provention Bio announced today that it has entered into agreements with Janssen to in-license two clinical-stage assets